Rx Fundamental Growth Fund Institutional Class (FMFGX)

12.59
Net Asset Value
-2.48%
1 Day
+7.15%
Year-to-Date
Overall Morningstar Rating
Mid-cap growth
Style or Category
No Load
Sales Expenses
1.63%
Expense Ratio
--
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund's investment sub-advisor, Navellier & Associates, Inc. (the "Sub-Advisor"), seeks to achieve the fund's investment objective of capital appreciation by principally investing in stocks that the Sub-Advisor believes to have above-average growth potential relative to their peers. It invests principally in common stocks and is not limited in its investments by market capitalization.

Performance

1 month-1.41% 3 years--
3 months0.00% 5 years--
1 year+8.25% Since inception+16.31%
Data through --

Peer Comparisonvs. Mid-cap growth

 FMFGXCategory
Performance 5-yr return--+14.47%
Expense ratio1.63%1.32%
Risk 5 year sharpe ratio--1.03
Net assets$60.5M$1.4B
Average market cap$12.3B$9.7B
Average P/E23.325.7
Portfolio turnover----

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFolioMetrix
Fund manager & tenureLouis Navellier / 1 Years
Minimal initial investment$250.00
Minimum IRA investment--

Holdings

U.S. stock88.94%
International stock10.88%
Cash0.18%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
SWKS Skyworks Solutions Inc3.02%
RAI Reynolds American3.00%
MO Altria Group2.92%
AAPL Apple2.80%
VDSI VASCO Data Security International Inc2.67%
GILD Gilead Sciences2.45%
HCP HCP Inc2.42%
NXPI NXP Semiconductors NV2.41%
PANW Palo Alto Networks Inc2.34%
AGN Allergan2.32%

To view my watchlist

Not a member yet?

Sign up now for a free account